# Oxford Pharmaceuticals, LLC, Birmingham, AL – FDA Inspections

Source: https://www.keypedia.com/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee

> Inspection records and compliance data for Oxford Pharmaceuticals, LLC in Birmingham, Alabama. 4 FDA inspections on record, 3 Form 483s, last inspected September 02, 2026.

---

## Details

- Name: Oxford Pharmaceuticals, LLC
- FEI Number: 3012257735
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: 301 Leaf Lake Pkwy
- City: Birmingham
- State: Alabama
- Zip Code: 35211
- Country Name: United States
- Address: 301 Leaf Lake Pkwy, Birmingham, Alabama 35211, United States
- Country: United States

## Related Documents

- [FDA Inspection 1334078 - Oxford Pharmaceuticals, LLC - 2026-09-02](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/4e4530db-12c1-4327-b044-4ed5c783ab5a) — source: FDA, date: September 2, 2026
- [483 - Oxford Pharmaceuticals, LLC - 2023-11-03](https://www.keypedia.com/records/483/oxford-pharmaceuticals-llc/d7066e3b-80a9-49c8-bb95-75cc0bc54434) — source: FDA, date: November 3, 2023
- [FDA Inspection 1221787 - Oxford Pharmaceuticals, LLC - 2023-11-03](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/0e32951c-75a0-4d53-b01e-ec21522685b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2023
- FDA Inspection 1174389 - Oxford Pharmaceuticals, LLC - 2022-06-08 — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2022
- [EIR - Oxford Pharmaceuticals, LLC - 2019-05-22](https://www.keypedia.com/records/eir/oxford-pharmaceuticals-llc/405ce7ff-4693-4316-9e17-8920acf85d44) — source: FDA, date: May 22, 2019
- [483 - Oxford Pharmaceuticals, LLC - 2019-05-22](https://www.keypedia.com/records/483/oxford-pharmaceuticals-llc/12185de3-9376-4a55-8a10-b505825c82f9) — source: FDA, date: May 22, 2019
- [FDA Inspection 1092451 - Oxford Pharmaceuticals, LLC - 2019-05-22](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/820c91ad-1442-4bd2-96b0-84faa633141e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2019

## Related Companies

- [Recipharm Monts](https://www.keypedia.com/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6)
- [Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206)
- [InvaTech Pharma Solutions, LLC](https://www.keypedia.com/companies/invatech-pharma-solutions-llc/a4957f07-dcf0-47ec-a41a-7effe7e4a8e3)
- [Maiva Pharma Private Limited](https://www.keypedia.com/companies/maiva-pharma-private-limited/3231d685-f5ad-401e-b1ae-66c6a6d8e8b7)
- [Indoco Remedies Limited (Plant I)](https://www.keypedia.com/companies/indoco-remedies-limited-plant-i/cdf789a3-1db2-4bf5-92b5-d6771ea5df48)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)
- [Novitium Pharma LLC](https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a)

## Related Officers

- [Investigator/Consumer Safety Officer](https://www.keypedia.com/people/francis-a-guidry/fd6d2a17-7f94-4f7c-8284-ad1f07d703e9)
- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)
- [Program Coordinator](https://www.keypedia.com/people/martrice-a-packer/e9d89635-6323-4dc7-9222-c44cedcf46c2)
